Medicare’s $50 GLP-1 Bridge: Who Qualifies and What It Excludes
CMS’s temporary Medicare GLP-1 Bridge offers selected beneficiaries a $50 monthly route to certain weight-loss drugs, but strict eligibility limits apply.
Prescription Drugs
-
-
FDA Posts Nationwide Recall of Papaverine Injection After Visible Particles Found
The FDA posted a nationwide recall for one lot of papaverine injection after visible glass or paraformaldehyde particles were found in the prescription drug.
-
Medicare GLP-1 bridge starts with $50 copay and tight eligibility rules
CMS has launched a temporary national Medicare program that offers some eligible Part D beneficiaries GLP-1 weight-loss drugs for $50 a month.